Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan, Mitoxantrone, and Etoposide in Refractory Hematologic Malignancies
NCT00100477Phase 2Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Aug 1998
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in acute leukemia, chronic myelogenous leukemia (CML), multiple myeloma (MM), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by United States Department of Veterans Affairs. Started Aug 1998; status: completed.
02
Drugs
topotecan
03
Conditions
acute leukemiachronic myelogenous leukemia (CML)multiple myeloma (MM)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00100477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100477.